Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-02-27 @ 11:19 AM
Study NCT ID:
NCT01682460
Status:
COMPLETED
Last Update Posted:
2017-06-05
First Post:
2012-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
Sponsor:
University of Waterloo
Organization:
Study Overview
Official Title:
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IVES
Brief Summary:
Research indicates that many people who are being treated for glaucoma have dry eyes. The purpose of this study is to test the use of artificial tears to alleviate dryness signs and symptoms in people who are using medication to treat glaucoma. The study hypothesis is that the use of artificial tears will result in an improvement in clinical signs and symptoms associated with dry eyes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: